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Multiple Plasmodium falciparum Erythrocyte Membrane Protein 1
Variants per Genome Can Bind IgM via Its Fc Fragment Fc
Anine Jeppesen,a Sisse Bolm Ditlev,a Vladyslav Soroka,a Liz Stevenson,a Louise Turner,a Ron Dzikowski,b Lars Hviid,a Lea Barfoda
Centre for Medical Parasitology, University of Copenhagen and Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmarka; Department of Microbiology
and Molecular Genetics, The Institute for Medical Research Israel-Canada, The Kuvin Center for the Study of Infectious and Tropical Diseases, The Hebrew University-
Hadassah Medical School, Jerusalem, Israelb
The Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) adhesive proteins expressed on the surfaces of infected
erythrocytes (IEs) are of key importance in the pathogenesis of P. falciparummalaria. Several structurally and functionally de-
fined PfEMP1 types have been associated with severe clinical manifestations, such as cerebral malaria in children and placental
malaria in pregnant women. PfEMP1 that can bind the Fc part of IgM (Fc) characterizes one such type, although the functional
significance of this IgM binding to PfEMP1 remains unclear. In this study, we report the identification and functional analysis of
five IgM-binding PfEMP1 proteins encoded by P. falciparumNF54. In addition to the VAR2CSA-type PFL0030c protein, already
known to bind Fc and to mediate chondroitin sulfate A (CSA)-specific adhesion of IEs in the placenta, we found four PfEMP1
proteins not previously known to bind IgM this way. Although they all contained Duffy binding-like  (DBL) domains similar
to those in VAR2CSA-type PfEMP1, they did not mediate IE adhesion to CSA, and IgM binding did not shield IEs from phagocy-
tosis of IgG-opsonized IEs. In this way, these new IgM-binding PfEMP1 proteins resemble the rosette-mediating and IgM-bind-
ing PfEMP1 HB3VAR06, but none of themmediated formation of rosettes. We could map the capacity for Fc-specific IgM bind-
ing to DBL domains near the C terminus for three of the four PfEMP1 proteins tested. Our study provides new evidence
regarding Fc-dependent binding of IgM to PfEMP1, which appears to be a common andmultifunctional phenotype.
Manymicroorganisms expressmolecules that can bind immu-noglobulins independently of the antigen specificity of the
antibodies. A prominent example is the antibody-binding pro-
teins found in the cell wall of the bacterium Staphylococcus aureus
(1, 2). These proteins have high affinities for the conserved ele-
ments in the Fc and Fab parts of various antibody classes, and they
appear to serve an immunoevasive function, as binding of anti-
bodies to these proteins interferes with phagocytosis of antibody-
opsonized bacteria (3).
Some erythrocytes infected by the malaria parasite Plasmo-
dium falciparum bind IgM, but not IgG, independently of the
specificity of the antibodies (4, 5). This Fc-mediated binding of
IgMhas been described for infected erythrocytes (IEs) that bind to
the sulfated glycosaminoglycan chondroitin sulfate A (CSA) (5)
and for IEs capable of forming rosettes (several uninfected eryth-
rocytes adhering to a central IE) (4). Both IE phenotypes are re-
lated to expression of particular types of P. falciparum erythrocyte
membrane protein 1 (PfEMP1). Thus, adhesion of IEs to CSA
requires expression of the atypical PfEMP1 typeVAR2CSA, which
has nanomolar affinity for CSA and is responsible for placental IE
sequestration (6–9). Rosetting can be mediated by several differ-
ent PfEMP1 proteins that have a semiconserved N-terminal head
structure made up of certain subtypes of Duffy binding-like 
(DBL)–cysteine-rich interdomain region / (CIDR/) do-
mains (10–13), and it appears to dependmainly on relatively low-
affinity interactions with a range of host carbohydrates (14–17).
The function of Fc-dependent binding of IgM to P. falciparum
IEs is not fully understood (reviewed in reference 18). In the case
of VAR2CSA-type PfEMP1, it appears to be mainly immunoeva-
sive, as it can protect IEs from specific IgG recognition and im-
mune destructionwithout compromising theCSA-adhesive func-
tion of the antigen (19). However, such masking is ineffective in
the case of rosette-mediating PfEMP1 antigens (15), where bind-
ing of IgM to PfEMP1—in combination with other serum fac-
tors—seems to function to increase the low-affinity adhesive in-
teractions involved in rosetting (15, 20). Given the apparent
clinical importance of IgMbinding (4, 21), it is of interest to know
howmany IgM-bindingPfEMP1 variants exist within the PfEMP1
repertoire of a single P. falciparum clone and how IgM binding is
related to the structural and functional characteristics of the
involved PfEMP1 proteins. We therefore set out to identify
IgM-binding PfEMP1 proteins in P. falciparum NF54. We show
that the genes for at least five IgM-binding PfEMP1 variants exist
in the genome of this parasite. In addition to PFL0030c, which is
the VAR2CSA-type antigen in P. falciparumNF54, we found four
others (PFL0020w, PF07_0139, MAL6P1.4, and MAL6P1.316).
Surprisingly, these did not mediate rosetting in functional assays
and do not possess structural features indicative of being rosette
mediating. Our study shows that Fc-mediated binding of IgM to
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PfEMP1 proteins is not limited to those that can adhere to CSA or
mediate formation of rosettes.
MATERIALS AND METHODS
Recombinant PfEMP1 proteins and specific antisera and monoclonal
antibodies.Recombinant proteins representing full-length PFL0030c and
single- and triple-domain constructs of MAL6P1.4, MAL6P1.316,
PFL0020w, and PFL0030c were produced in a baculovirus expression sys-
tem, essentially as described previously (15, 22). The domain nomencla-
ture proposed by Rask et al. in 2010 is used throughout (23). Antisera
against MAL6P1.4, MAL6P1.316, and PFL0020w were raised in rats (24),
and the human monoclonal antibody PAM1.4, specific for several
VAR2CSA-type PfEMP1 proteins, including PFL0030c, was generated as
described elsewhere (25, 26). Nonimmune IgM binding to recombinant
PfEMP1 constructs was quantified by enzyme-linked immunosorbent as-
say (ELISA) as described previously (15).
Malaria parasite cultivation and in vitro selection procedures. P.
falciparumNF54 parasites (27) were grown in vitro in O Rh erythrocytes
at 37°C in a controlled atmosphere, using complete culture medium
(RPMI 1640 supplemented with 0.5%AlbuMax II [Life Technologies BV,
Nærum, Denmark]), essentially as described previously (28). The P. fal-
ciparum NF54-derived and pVBH-transfected clone G6 was generated as
described elsewhere (29–31). It was maintained in the same way as the
parental strain P. falciparumNF54, except that blasticidin (10mg/ml; Life
Technologies) was added to shut down transcription of endogenous var
genes and to erase the epigenetic memory. IEs were selected for surface
expression of defined PfEMP1 proteins by immunomagnetic selection
using (i) PfEMP1-specific rat antisera followed by biotinylated anti-rat
antibody (Dako) and streptavidin-coupled Dynabeads (Fisher Scientific)
or (ii) PAM1.4 followed by protein A-coupled Dynabeads (Fisher Scien-
tific), essentially as described previously (32). For selection of IgM-bind-
ing IEs, we used human IgM (Sigma) coupled toM-450 epoxy beads (Life
Technologies) according to the manufacturers’ instructions. The geno-
typic identity of the parasites and the absence ofMycoplasma contamina-
tion were verified regularly as described previously (33).
var gene transcription analysis. For analysis of var gene transcription
by quantitative real-time PCR, we used cDNA generated from ring-stage
parasite RNA and P. falciparum 3D7 var gene-specific primers as de-
scribed in detail elsewhere (6, 34, 35). Transcription levels relative to those
of the seryl-tRNA synthetase housekeeping gene were calculated by the
2CT method.
Antibody labeling of IEs. The binding of nonimmune IgM and
PfEMP1-specific antibody to IEs was quantified by flow cytometry, essen-
tially as described previously (19). In brief, we usedmagnetically activated
cell sorting (MACS) to purify late-stage IEs, labeled with ethidium bro-
mide (10mg/ml), serial dilutions of human IgM, and secondary antibody.
Human IgA was used as a negative control for IgM. In some experiments,
IgM (100 nM) was preincubated (20 min, room temperature) with
equimolar concentrations of mouse monoclonal antibodies specific for
human Fc2 (HB57), Fc3 (5D7), or Fc4 (1G6) (all described in refer-
ence 36) ormouse control IgG (Sigma). Three replicatesweremeasured in
each experiment. The purification of late-stage IEs byMACS was assessed
by ethidium bromide staining as described above, and IE surface expres-
sion of the expected PfEMP1 protein was verified by labeling with
PfEMP1-specific antisera or human monoclonal antibody. All list-mode
data files were analyzed using Winlist 6.0 (Verity, Topsham, ME).
Single-cell cloning of IgM-binding IEs. P. falciparum G6 grown un-
der blasticidin pressure to erase the epigenetic memory of var gene tran-
scription was released from the selection pressure for 2 weeks to obtain a
populationwith highly heterogeneous var gene transcription, as described
previously (31). MACS-purified late-stage IEs were labeled with human
IgM (10 nM, 30 min, 4°C), washed thrice in sterile phosphate-buffered
saline (PBS) supplemented with fetal bovine serum (2%), stained with
phycoerythrin-conjugated donkey anti-human IgM (Jackson Immuno-
Research, Newmarket, United Kingdom) (1:200, 30 min, 4°C), and
washed thrice as described above. An Aria-II fluorescence-activated cell
sorter (BD Biosciences, San Jose, CA) was used to single-cell sort IgM-
positive IEs into round-bottomed 96-well plates (Thermo Fisher Scien-
tific, Roskilde, Denmark) containing complete culture medium (200 l/
well) and uninfected erythrocytes (2 l/well). Some wells received 50 IEs
rather than a single IE. The 96-well plates were incubated for 2 weeks
(37°C, 5% CO2), with a change of medium thrice weekly and addition of
uninfected erythrocytes (2 l/well) twice weekly. Small aliquots of IEs
were stained with ethidium bromide (2 g/ml), IgM (10 nM), and fluo-
rescein isothiocyanate-conjugated anti-human IgM (Sigma; 1:150) and
used to assess parasite growth and IgMbinding by flow cytometry, using a
Beckman Coulter FC500 instrument (Beckman Coulter, Fullerton, CA).
Clones with IgM-positive IEs were transferred and expanded further in
tissue culture flasks.
Adhesion of IEs to CSA. Adhesion of IEs to CSA-expressing BeWo
cells was determined essentially as described previously (37). In brief,
ring-stage IEs were labeled with [3H]hypoxanthine for 24 h. BeWo cells
(LGC Promochem, Borås, Sweden) were grown to confluence in flat-
bottomed 96-well plates (Thermo Fisher Scientific, Denmark) and
blocked with bovine serum albumin (5% in PBS, 1 h). MACS-purified
[3H]hypoxanthine-labeled late-stage IEs (2 	 105 IEs/well) were added
and incubated (37
C, 1 h). Unbound IEs were washed off by use of a
Biomek 2000 automated plate washer (Beckman Coulter). After washing,
MACS-purified [3H]hypoxanthine-labeled late-stage IEs (2 	 105 IEs/
well) were added to three empty wells as a measure of maximal binding.
The IEs were harvested onto Optiplate-96 filters (PerkinElmer,Waltham,
MA), Microscint40 scintillation liquid (PerkinElmer; 50 l/well) was
added, and [3H]hypoxanthine incorporation was determined on a Top-
Count NXT scintillation counter (PerkinElmer).
Rosetting assay. Ring-stage IEs were incubated overnight (37°C, 5%
CO2) in RPMI 1640 supplementedwith either nonimmune human serum
(10%) or AlbuMax II (0.5%). After labeling of parasites with ethidium
bromide (25 g/ml), rosetting frequencies were assessed by counting 200
ethidium bromide-stained IEs, using wet-slide preparations and fluores-
cence microscopy. Rosettes were defined as IEs having two or more ad-
hering uninfected erythrocytes. All assays were done in triplicate.
Phagocytosis assay. Phagocytosis of antibody-opsonized IEs was
measured as described previously (38). In brief,MACS-purified late-stage
IEs were stained with ethidium bromide (100 g/ml, 10 min, room tem-
perature), washed twice in RPMI supplemented with 2% fetal bovine
serum, labeled with either human IgM or human IgA (50 nM), and op-
sonized with pooled plasma pools from nonexposed or P. falciparum-
exposed adults (1:10, 30 min, room temperature). After washing as de-
scribed above, the IEs were incubated in 4-ml tubes (30 min, 37°C, 5%
CO2) with cells of the human monocytic leukemia line THP-1 (TIB-202;
LGC Standards, Borås, Sweden) at a 20:1 ratio. Following lysis of remain-
ing free IEs (15 mMNH4Cl, 10 mMNaHCO3,1 mM EDTA), the propor-
tion of ethidium bromide-positive THP-1 cells was determined by flow
cytometry using an FC500 instrument (Beckman Coulter).
Binding kinetic analysis. We used a Biacore 2000 instrument (GE
Healthcare, Hillerød, Denmark) tomeasure the affinity of IgM for recom-
binant PfEMP1 constructs by surface plasmon resonance analysis as de-
scribed previously (15). Following gel filtration, the recombinant PfEMP1
domain constructs (50 ml/min for 60 s), followed by buffer (120 s), were
flowed over IgM (750 relative units) immobilized on a CM4 biosensor
chip (GE Healthcare) by amine coupling. After each run, the chip was
regenerated with 20 mM NaOH. All experiments were performed in
HEPES buffer (0.01 M HEPES, 0.15 M NaCl, 3 mM EDTA, 0.005% [vol/
vol] surfactant P20, pH 7.4, 20°C). The specific binding response to IgM
was calculated by subtracting the response to an uncoupled chip and to
buffer injection. The kinetic sensorgrams were fitted to a global 1:1 inter-
actionmodel to allow calculation of the ka,Kd (dissociation constant), and
KD (equilibrium dissociation constant) values, using BIAevaluation soft-
ware v. 4.1 (GE Healthcare).
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Statistical analysis. One-way analysis of variance followed by Holm-
Sidak multiple pairwise comparisons was used to evaluate the capacity of
Fc-specific antibodies to inhibit binding of IgM to IEs, and Student’s t
test was used to evaluate the ability of IgM and IgA to inhibit phagocytosis
of IgG-opsonized IEs. P values of0.05 were considered statistically sig-
nificant.
RESULTS
Identification of candidate IgM-binding PfEMP1 proteins in P.
falciparumNF54.We used the P. falciparumNF54-derived clone
G6 to identify IgM-binding PfEMP1 proteins. This clone, which is
transfected with a pVBH plasmid containing a blasticidin resis-
tance gene controlled by a var promoter, initially transcribed the
var gene pfd1015c (31). Culturing this parasite under high blasti-
cidin selection pressure results in a complete shutdown of endog-
enous var transcription and erasure of epigenetic memory, and
removal of drug pressure allows in vitro var switching to begin
(31).We labeled IEswith IgMand single-cell sorted IgM-positive IEs
into 96-well plates. Four cell-sorting control lineswith 50 IEs perwell
were also established. After in vitro expansion for 3 weeks, we had 19
growing cultures originating from individual single-cell-sorted IEs.
var gene transcription was assessed in all lines containing IgM-posi-
tive IEs (eight from subclones and two from the 50-cell control sub-
lines). Each of the subclones transcribedmultiple var genes as a result
of shifts in var transcription during the period of in vitro expansion
(Fig. 1A). Nevertheless, all but one subclone (G6.2.5) and one 50-cell
subline (G6.1.13) showed dominant expression of a single var gene.
One subclone (G6.3.16) and one 50-cell subline (G6.1.14) mainly
transcribed pfl0030c. Four clones (G6.1.57, G6.2.20, G6.2.56, and
G6.2.79) mainly transcribed pfl0020w, two (G6.3.40 and G6.3.76)
predominantly transcribed pf07_0139, and both the 50-cell sublines
showed prominent transcription of mal6p1.316. The relative tran-
scription levels of the identified candidate var genes were reflected in
the proportions of erythrocytes infected by the subclones and sub-
lines that bound IgM (Fig. 1A).
FIG 1 var gene transcription in P. falciparum G6 following subcloning. (A) Distributions of var transcripts in progenies of single-cell-sorted subclones and
50-cell-sorted sublines (G6.1.13 and G6.1.14) of IgM-positive P. falciparumG6 following 3 weeks of expansion in vitro. Transcripts are color coded as described
by Fastman et al. (31), according to the grouping scheme described by Lavstsen et al. (61). The groups identified are group A (gray), group B/A (orange), group
B (blue), group B/C (green), group C (red), and VAR2CSA (white). The major transcripts are identified by name, and all candidate genes selected are shown as
“exploded pie slices.” The percentage of corresponding IEs binding IgM is indicated in parentheses below the pie for each subclone. (B) Domain structures of the
PfEMP1 proteins encoded by major var gene transcripts in these subclones and sublines. The orientation and domain numbers are indicated in italics along the
top of the panel. Recombinant PfEMP1 constructs used in the present study are indicated by underlining.
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The PfEMP1 protein encoded by the pfl0030c var gene in P.
falciparum NF54 is the CSA-adhering VAR2CSA-type protein
PFL0030c (6, 7). This protein is known to bind IgM via Fc (19,
39), and several DBL domains have been implicated in this bind-
ing (39, 40). Only the three C-terminal DBL domains in PFL0030c
are of a type (DBLε) that is also found in non-VAR2CSA-type
PfEMP1 proteins. All the non-VAR2CSA-type candidate IgM-
binding PfEMP1 proteins we identified above contained C-ter-
minal DBLε domains (Fig. 1B). However, we recently mapped
the Fc-binding domain in the rosetting PfEMP1 protein
HB3VAR06 to its C-terminal DBL_8 domain, and two of our
candidate var transcripts (pfl0020w and mal6p1.316) additionally
contain a DBL domain each (Fig. 1B). Together, these data point
to C-terminal DBLε and DBL domains as being relevant for Fc-
mediated IgM binding.
Verification of the IgM-binding properties of candidate
PfEMP1 proteins. To verify the predicted IgM-binding capacity
of our candidate PfEMP1 proteins, we next subjected previously
unselected P. falciparumNF54 parasites to repeated selection with
either theVAR2CSA-specificmonoclonal antibody PAM1.4 or rat
antisera to PFL0020w and MAL6P1.316. In addition, we selected
IEs by using a rat antiserum to the PfEMP1 protein MAL6P1.4,
because two of our subclones (G.6.256 and G6.2.79) showed
prominent transcription of mal6p1.4 (Fig. 1A). MAL6P1.4 con-
tains three C-terminal DBLε domains (Fig. 1B),making it a strong
IgM-binding candidate.We did not have an antiserum specific for
PF07_0139 and instead subjected subclone G6.3.40 to repeated
rounds of selection for IgM binding. As a negative control, we
used P. falciparum NF54 selected by an antiserum specific for the
intercellular adhesion molecule 1 (ICAM-1)-binding PfEMP1
protein PFD1235w (33, 41). These selection protocols all resulted
in parasites with dominant transcription of the expected var gene
(Fig. 2A), and all the selected IEs bound IgM to various degrees,
except for the IEs selected for expression of PFD1235w (Fig. 2B
and C).
Determination of the IgM domain involved in binding to
PfEMP1. We previously showed that the C3-C4 domains of
IgM bind to VAR2CSA-type PfEMP1 (19) and to the rosetting
PfEMP1 HB3VAR06 (15). We therefore measured the ability of
monoclonal antibodies specifically recognizing the C2, C3,
and C4 domains of human IgM to interfere with IgM binding to
IEs expressing each of the IgM-binding PfEMP1 proteins studied
here. In each case, all three Fc-specific antibodies significantly
(P 0.001 in all cases) reduced the binding of IgM to the IEs (Fig.
3), although the C2-specific antibody was less effective than the
other two antibodies at inhibiting IgM binding to the VAR2CSA-
type PFL0030c protein, in accordancewith previous findings (19).
Determination of the PfEMP1 domains involved in Fc-spe-
cific binding of IgM. Multiple domains have been implicated in
Fc-dependent binding of IgM to PfEMP1 (15, 39, 40, 42, 43). We
recently used multiple recombinant single- and multi-DBL-do-
main constructs to map this type of IgM binding to the penulti-
mate C-terminal DBL (DBL_8) domain in the rosette-mediating
PfEMP1 HB3VAR06 (15). Taking a similar approach here, we
used ELISA to identify the domains involved in IgM binding, em-
ploying an array of recombinant proteins representing single
and triple domains of PFL0030c, PFL0020w, MAL6P1.4, and
MAL6P1.316, as well as a construct representing the full ectodo-
main of PFL0030c (see Fig. 1B for an overview of the recombi-
nant antigen constructs used).With this approach, we unequiv-
ocally identified DBLεPAM5 as the IgM-binding domain in the
VAR2CSA-type PFL0030c protein (Fig. 4A). This is the penulti-
mate C-terminal DBL domain in that protein and was the most
prominent IgM-binding domain in an earlier study of VAR2CSA-
type PfEMP1 (39). Similarly, we mapped the IgM-binding capac-
ity of PFL0020w and MAL6P1.4 to their C-terminal domains
(DBLε4_6 and DBLε3_9, respectively) (Fig. 4B). MAL6P1.4 con-
tained an additional IgM-binding domain (DBLε2_7). We were
unable to map the IgM-binding domain ofMAL6P1.316 with our
recombinant constructs.
We used surface plasmon resonance analysis to show that the
binding affinity of IgM for each of the domains identified to bind
IgM by ELISA was high, with KD values in the nanomolar range
(Table 1), which is the same range as that reported previously (15).
Triple-domain constructs had higher affinities (lower KD values)
than single-domain constructs, which may be related to the con-
struct conformation but likely also reflects the fact that two IgM-
binding domains (DBLε2_7 and DBLε4_9) were present in our
MAL6P1.4 triple-domain construct (Fig. 4 and Table 1).
FIG 2 IgM binding and relative var gene transcription in P. falciparum NF54
following antibody selection. (A) Distributions of var transcripts in P. falcipa-
rumNF54 following antibody selection for IE surface expression ofMAL6P1.4,
PFL0030c, MAL6P1.316, PFL0020w, and PF07_0139. The color coding and
layout are as described in the legend to Fig. 1. (B) Titration of IgM binding to
erythrocytes infected by the corresponding subclones and sublines. Means
(symbols) and standard deviations (error bars) for triplicatemeasurements are
shown. MFI, mean fluorescence intensity. (C) Histograms showing represen-
tative flow cytometry data on all selected parasite cultures, with (orange/white/
blue) or without (gray) IgM. PE, phycoerythrin.
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All constructs displayed rapid association kinetics, with ka val-
ues of 1	 106 to 10	 106M1 s1. The dissociation kinetics were
more variable but were slower for the triple-domain constructs
than the corresponding single-domain constructs, suggesting that
the higher-order conformation of the PfEMP1 proteins contrib-
utes to retention of IgM once it is bound.
CSA-binding and rosetting properties of the new IgM-bind-
ing PfEMP1 proteins. Fc-dependent IgM binding to PfEMP1 has
previously been shown for parasites expressing CSA-adherent
VAR2CSA-type or rosette-mediating PfEMP1 variants (reviewed
in reference 18). We therefore tested the abilities of erythrocytes
infected by P. falciparum expressing either PFL0030c or each of
the four new non-VAR2CSA-type PfEMP1 proteins to bind to
CSA and to form rosettes. We included parasites expressing the
PfEMP1 protein HB3VAR06 as a positive control in the rosetting
assays, as this PfEMP1 is known to mediate IgM-dependent ro-
sette formation (15). IEs expressing the VAR2CSA-type PFL0030c
protein adhered strongly to CSA-expressing BeWo cells, in accor-
dance with previous reports (6, 37), while none of the other
PfEMP1 proteins mediated significant adhesion to this receptor
(Fig. 5A). None of the five IgM-binding PfEMP1 proteins studied
here was able to mediate formation of rosettes (Fig. 5B). We previ-
ously reported that HB3VAR06-mediated rosetting requires soluble
serum factors (15, 20), but serum did not lead to rosetting in IEs
expressing any of our new IgM-binding PfEMP1 proteins (Fig. 5B).
IgM-mediated interference with phagocytosis of IgG-op-
sonized infected erythrocytes. Fc-dependent IgM binding to
FIG3 IgMdomains involved inbinding toPfEMP1proteins. (A) Involvement of
Fc domains in the binding of IgM to PfEMP1 as determined by the interference
ofmonoclonal antibodies tovariousFcdomains (C1,C2, andC3)with IgM
binding to selected PfEMP1 proteins. Overall means (histograms) and standard
deviations (error bars) for three independent experiments are shown. Statistically
significantdifferences (P0.001) relative to thenegativecontrols (mouse IgG)are
indicated by asterisks. (B) Representative flow cytometry data forMAL6P1.4 and
PFL0030c. Each histogram shows an overlay of no IgM (gray) and IgMwith anti-
IgM or control mouse antibodies (white). FITC, fluorescein isothiocyanate.
FIG 4 PfEMP1 domains involved in IgM binding. The graphs show the ability
of domains in VAR2CSA-type (A) and non-VAR2CSA-type (B) PfEMP1 pro-
teins to bind IgM (white) and IgA (black). Means (histograms) and standard
deviations (error bars) for triplicate measurements from a representative ex-
periment (of three) are shown. Domains are numbered as described in the
legend to Fig. 1B.
Jeppesen et al.
3976 iai.asm.org October 2015 Volume 83 Number 10Infection and Immunity
 o
n
 Septem
ber 12, 2015 by guest
http://iai.asm
.org/
D
ow
nloaded from
 
VAR2CSA-type PfEMP1markedly inhibits the binding of specific
IgG to the IE surface and subsequent phagocytosis of opsonized
IEs (19). However, this is not the case for parasites expressing the
rosette-mediating HB3VAR06 protein, as IgM binding has a lim-
ited effect on the phagocytosis of antibody-opsonized IEs (15). To
test whether IgM could inhibit binding of PfEMP1-specific IgG to
IEs positive for each of the new IgM-binding PfEMP1 proteins
identified here, we opsonized the IEs with immune human plasma
in the absence or presence of IgM and subsequently measured
phagocytosis by using a robust in vitro assay (38). Phagocytosis of
IEs expressing the VAR2CSA-type PFL0030c protein was mark-
edly (about two-thirds) and significantly reduced in the presence
of IgM, in accordance with previous data (19) (Fig. 6). A smaller
or nonsignificant impact of IgM on IgG-dependent phagocy-
tosis was seen for each of the other PfEMP1 proteins (Fig. 6). In
this respect, they therefore resembled the rosette-mediating
PfEMP1 HB3VAR06 (15), although none of them appear to be
involved in rosetting (Fig. 5B).
DISCUSSION
The particular virulence of P. falciparum parasites is related to
their ability to express members of the clonally variant protein
family PfEMP1 on the surfaces of the erythrocytes they infect (re-
viewed in reference 44). The PfEMP1 proteins mediate adhesion
of IEs to different host receptors in various tissues to avoid IE
destruction in the spleen (45). Each parasite genome contains
about 60 PfEMP1-encoding var genes that are transcribed in a
mutually exclusive manner (46–48). Thus, normally only one
PfEMP1 is expressed on the IE surface at any given time, but the
parasites can switch transcription among the different var genes
from one asexual 48-h multiplication cycle to the next, thereby
TABLE 1 Surface plasmon resonance analysis of IgM binding to recombinant PfEMP1 domains
PfEMP1 Domain(s)
Mean SDa
ka (M
1 s1) Kd (s
1) KD (nM)
b
MAL6P1.4 DBLε2_7-DBLε7_8-DBLε3_9 1.21	 106 1.02	 106 7.19	 104 2.73	 104 2.07 2.78
DBLε2_7 7.14	 105 5.32	 105 5.03	 103 1.24	 103 14.80 7.43
DBLε7_8 NA NA NA
DBLε3_9 8.58	 105 6.18	 105 9.63	 103 0.58	 103 66.06 56.22
PFL0020w DBL14_4-DBL5_5-DBLε4_6 3.25	 106 0.63	 106 3.71	 103 1.15	 103 2.36 2.31
DBLε4_6 5.23	 105 5.25	 105 9.92	 103 2.97	 103 66.52 45.38
PFL0030c DBLεPAM5_6 5.96	 10
5 3.1	 105 3.98	 102 1.97	 103 140.02 77.91
a NA, not available because the domain did not bind IgM.
b The KD values were calculated based on a 1:1 binding model from 3 to 6 independent analyses, with 4 to 8 different concentrations tested in duplicates per analysis, and the values
are shown with composite standard deviations.
FIG 5 Functional properties of erythrocytes infected by P. falciparum para-
sites expressing defined PfEMP1. The graphs show the ability of IE surface-
expressed PfEMP1 proteins to mediate adhesion to CSA on BeWo cells (A) or
to mediate rosetting (B) in the presence (white) or absence (black) of serum.
Means (bars) and standard deviations (error bars) for triplicatemeasurements
from a representative experiment (of three) are shown.
FIG 6 IgM-dependent interference with phagocytosis of IgG-opsonized in-
fected erythrocytes. The graph shows the ability of IgM (white) and IgA (black)
to interfere with IgG-specific opsonization and phagocytosis of erythrocytes
infected by P. falciparum parasites expressing defined PfEMP1. Overall means
(bars) and standard deviations (error bars) for three independent experiments
are shown. **, significant differences between the two bars.
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changing the adhesive and antigenic properties of the IEs (46, 47).
By now, it is clear that certain structurally defined and functionally
related PfEMP1 subfamilies are involved in particular types of
severe malaria (reviewed in reference 49). The role of endothelial
protein C receptor (EPCR)-adhering PfEMP1 proteins sharing
domain cassette 8 (DC8) and DC13 motifs (50, 51) in the patho-
genesis of cerebral malaria is a recent example. The similar role of
DC4-containing PfEMP1 proteins adhering to ICAM-1 is another
(33). Finally, VAR2CSA-type PfEMP1 proteins adhering to CSA
have a well-established key role in the pathogenesis of placental
malaria (reviewed in reference 52). The tissue-specific adhesion
mediated by these types of PfEMP1 makes it easy to appreciate
their role in pathogenesis. It ismuch less obviouswhy the ability of
some PfEMP1 proteins to bind IgM via Fc should be linked to
malaria severity, as has repeatedly been shown (reviewed in refer-
ence 18). Several PfEMP1 domains have been implicated in IgM
binding (15, 36, 39, 40, 42, 43), but a unifying picture has not yet
emerged. Furthermore, it is unclear whether Fc-specific binding
of IgM to IEs is restricted to parasites expressing PfEMP1 proteins
that can adhere toCSAor lead to the formation of rosettes. Finally,
it is not known howmany PfEMP1 proteins encoded by any single
P. falciparum genome possess this phenotype. Thus, the purpose
of the present study was to address these unanswered questions.
Individual P. falciparum parasites transcribe only a single var
gene at a time, and this mutually exclusive transcription ensures
that normally only a single PfEMP1 variant is present on the sur-
face of any given IE (53–55). Even at the population level, the
diversity of PfEMP1 expression is often limited due to the pres-
ence of epigenetic memory (reviewed in references 56 and 57). To
overcome this difficulty, we selected pVBH-transfected P. falcipa-
rum G6 clonal parasites for resistance to blasticidin, which effec-
tively erases the epigenetic var gene transcription memory (29–
31). Following induction of var switching, we single-cell sorted IEs
from this population based on their capacity to bind IgM at the IE
surface, and we obtained subclones and sublines with dominant
transcription of four different var genes (Fig. 1). One was pfl0030c
(6), which encodes the VAR2CSA-type PfEMP1 in the P. falcipa-
rum 3D7 clone (from which the G6 clone is derived) and was
already known to bind IgM via Fc (19, 39, 40). The other three
(mal6p1.316, pfl0020w, and pf070139) encode PfEMP1 proteins
not previously reported to bind IgM. However, all contain at least
one DBLε-type domain, similar to the C-terminal domains previ-
ously implicated in the IgM-binding capacity of VAR2CSA-type
PfEMP1 (39, 40). Finally, the var genemal6p1.4, which encodes a
PfEMP1 with three C-terminal DBLε domains in tandem, was
also prominently transcribed in several subclones/sublines.
These structural characteristics supported the IgM-binding ca-
pacity of these PfEMP1 variants. Two of the genes (pf0020w
and mal6p1.316) additionally encode a C-terminal DBL do-
main. This further reinforced their candidature, as we recently
mapped Fc-specific binding of IgM to a domain of that type (15).
Indeed, we experimentally confirmed their ability to bind IgM
(Fig. 2).
The Fc-specific binding of IgM to PfEMP1 proteins has consis-
tently been shown to involve the C3-C4 domains in the Fc part
of pentameric IgM. Our findings confirm this location of the
PfEMP1-binding site in IgM (Fig. 3). More ambiguity exists with
respect to the corresponding PfEMP1 domains involved. Thus far,
at least three of the DBL domains in VAR2CSA-type PfEMP1
(DBLPAM2_2, DBLεPAM5_6, andDBLεPAM10_7) have been impli-
cated (39, 40). We resolved this uncertainty by using recombi-
nant constructs of each of the DBL domains in PFL0030c to
map the IgM-binding site to the penultimate N-terminal do-
main DBLεPAM5_6 (Fig. 4). Similar confusion has existed with
respect to IgM binding to non-VAR2CSA-type PfEMP1 proteins,
in which N-terminal cysteine-rich interdomain region  (CIDR),
central DBL, and C-terminal DBL domains have all been impli-
cated (15, 42, 43). We found that DBLε domains near the C ter-
minus were responsible for mediating binding to IgM in the
PfEMP1 proteins studied here. One of them (MAL6P1.4) even
contained two IgM-binding domains (DBLε2_7 and DBLε3_9),
something which has not been observed previously. Overall, pres-
ently available evidence points to DBLε and DBL domains near
or at the C terminus as the key IgM-binding elements in PfEMP1
proteins.
The functional significance of Fc-mediated binding of IgM to
PfEMP1 proteins remains unclear (18). In the case of VAR2CSA-
type PfEMP1, it appears to serve an immunoevasive role that in-
terferes with phagocytosis of IgG-opsonized IEs without compro-
mising the adhesive function of PfEMP1 (19). Our findings here
support these earlier results. Thus, PF0030c-expressing IEs ad-
hered strongly to CSA, whether IgM was present or not (Fig. 5A),
and IgM markedly inhibited phagocytosis of IgG-opsonized IEs
expressing this PfEMP1 (Fig. 6). In contrast to these characteris-
tics of VAR2CSA-type PfEMP1, we recently reported that Fc-de-
pendent binding of IgM does not protect parasites expressing the
rosette-mediating HB3VAR06 protein from phagocytosis of IgG-
opsonized IEs but rather may serve to augment low-affinity adhe-
sive interactions between the PfEMP1 head structure and as yet
undefined carbohydrate moieties (15). Fc-specific binding of
IgM to the new PfEMP1 proteins identified here did not mark-
edly protect them from phagocytosis following opsonization
by antigen-specific IgG (Fig. 6). In this respect, they resemble
the rosette-mediating PfEMP1 protein HB3VAR06, which sug-
gests that they have an elongated conformation. Only one of
them (MAL6P1.316) contains an N-terminal DBL domain of a
type previously associated with rosetting (DBL1.5, DBL1.6,
DBL1.8, or DBL2) (10–13, 15), and none of them mediated
rosetting (Fig. 5B). These findings establish for the first time that
the ability to bind IgM via Fc is not restricted to VAR2CSA-type
and rosette-mediating PfEMP1 variants. They also indirectly sup-
port our hypothesis that an important function of IgM binding is
to augment low-affinity adhesive interactions between the
PfEMP1 head structures and host endothelial receptors (15). Only
when such receptors are also found on erythrocytes would this
lead to rosetting.
In conclusion, we have provided evidence that each P. falcipa-
rum genome encodes several PfEMP1proteinswith the capacity to
bind Fc. We cannot formally rule out that other parasite-en-
coded IE proteins, e.g., rosette-mediating RIFINs (58, 59), also
have affinity for Fc, but there is presently no evidence to support
that possibility. We identified five PfEMP1 proteins in P. falcipa-
rum 3D7/NF54 parasites, but this is almost certainly an underes-
timation considering the limited number of subclones we investi-
gated. Our findings confirm that Fc-specific binding of IgM to
VAR2CSA-type PfEMP1 has an immunoevasive function. How-
ever, they also support recent data pointing to alternative roles for
Fc-mediated IgM binding to other types of PfEMP1 (15, 18, 20).
In any case, the IgM-binding phenotype is likely to be both com-
mon and important, as we showed that Fc-dependent binding of
Jeppesen et al.
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IgM is not restricted to PfEMP1 proteins mediating either adhe-
sion to CSA or rosetting. Although rosetting has been associated
with expression of PfEMP1 proteins causing severe malaria, the
relationship is not absolute (reviewed in reference 60). Indeed,
several PfEMP1 proteins that mediate adhesion to EPCR and
ICAM-1, phenotypes that have repeatedly been associated with
severe malaria, do not mediate formation of rosettes (50). Future
analysis of the interrelationship among various PfEMP1 pheno-
types that have been individually associated with malaria severity
may well produce important new insights. This prediction is sup-
ported by the fact that one of the PfEMP1 proteins studied here
(MAL6P1.316), which bound Fc but did not mediate formation
of rosettes, contains a CIDR of a type (CIDR1.8) that is involved
in adhesion to EPCR (51).
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